ACP3 and Familial prostate cancer: Prostatic Acid Phosphatase (PAP), Epithelial Cell Adhesion Molecule (EpCAM), and Transient Receptor Potential (Trp-p8) are other TAAs that are currently being studied which have the potential to become new CAR-T targets for prostate cancer.